Cargando…
Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation
AIMS: To investigate the exact prevalence of glucose metabolism disorders, and their impact on left atrial (LA) remodelling and reversibility in patients with atrial fibrillation (AF). METHODS AND RESULTS: We examined 204 consecutive patients with AF who underwent their first catheter ablation (CA)....
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228626/ https://www.ncbi.nlm.nih.gov/pubmed/37155360 http://dx.doi.org/10.1093/europace/euad119 |
_version_ | 1785051009762983936 |
---|---|
author | Nakanishi, Koki Daimon, Masao Fujiu, Katsuhito Iwama, Kentaro Yoshida, Yuriko Hirose, Kazutoshi Mukai, Yasuhiro Yamamoto, Yuko Nakao, Tomoko Oshima, Tsukasa Matsubara, Takumi Shimizu, Yu Oguri, Gaku Kojima, Toshiya Hasumi, Eriko Morita, Hiroyuki Komuro, Issei |
author_facet | Nakanishi, Koki Daimon, Masao Fujiu, Katsuhito Iwama, Kentaro Yoshida, Yuriko Hirose, Kazutoshi Mukai, Yasuhiro Yamamoto, Yuko Nakao, Tomoko Oshima, Tsukasa Matsubara, Takumi Shimizu, Yu Oguri, Gaku Kojima, Toshiya Hasumi, Eriko Morita, Hiroyuki Komuro, Issei |
author_sort | Nakanishi, Koki |
collection | PubMed |
description | AIMS: To investigate the exact prevalence of glucose metabolism disorders, and their impact on left atrial (LA) remodelling and reversibility in patients with atrial fibrillation (AF). METHODS AND RESULTS: We examined 204 consecutive patients with AF who underwent their first catheter ablation (CA). Oral glucose tolerance test was used to evaluate glucose metabolism disorders in 157 patients without known diabetes mellitus (DM). Echocardiography was performed before and 6 months after CA. Oral glucose tolerance test identified abnormal glucose metabolism in 86 patients [11 with newly diagnosed DM, 74 with impaired glucose tolerance (IGT) and 1 with impaired fasting glucose (IFG)]. Ultimately, 65.2% of patients had abnormal glucose metabolism. Diabetes mellitus group had the worst LA reservoir strain and LA stiffness (both P < 0.05), while there was no significant difference in baseline LA parameters between normal glucose tolerance (NGT) group and IGT/IFG group. The prevalence of LA reverse remodelling (≥15% decrease in the LA volume index at 6 months after CA) was significantly higher in NGT group compared with IGT/IFG and DM group (64.1 vs. 38.6 vs. 41.5%, P = 0.006). Both DM and IFG/IGT carry a significant risk of lack of LA reverse remodelling independent of baseline LA size and AF recurrence. CONCLUSION: Approximately 65% of patients with AF who underwent their first CA had abnormal glucose metabolism. Patients with DM had significantly impaired LA function compared with non-DM patients. Impaired glucose tolerance/IFG as well as DM carries significant risk of unfavourable LA reverse remodelling. Our observations may provide valuable information regarding the mechanisms and therapeutic strategies of glucose metabolism-related AF. |
format | Online Article Text |
id | pubmed-10228626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102286262023-05-31 Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation Nakanishi, Koki Daimon, Masao Fujiu, Katsuhito Iwama, Kentaro Yoshida, Yuriko Hirose, Kazutoshi Mukai, Yasuhiro Yamamoto, Yuko Nakao, Tomoko Oshima, Tsukasa Matsubara, Takumi Shimizu, Yu Oguri, Gaku Kojima, Toshiya Hasumi, Eriko Morita, Hiroyuki Komuro, Issei Europace Clinical Research AIMS: To investigate the exact prevalence of glucose metabolism disorders, and their impact on left atrial (LA) remodelling and reversibility in patients with atrial fibrillation (AF). METHODS AND RESULTS: We examined 204 consecutive patients with AF who underwent their first catheter ablation (CA). Oral glucose tolerance test was used to evaluate glucose metabolism disorders in 157 patients without known diabetes mellitus (DM). Echocardiography was performed before and 6 months after CA. Oral glucose tolerance test identified abnormal glucose metabolism in 86 patients [11 with newly diagnosed DM, 74 with impaired glucose tolerance (IGT) and 1 with impaired fasting glucose (IFG)]. Ultimately, 65.2% of patients had abnormal glucose metabolism. Diabetes mellitus group had the worst LA reservoir strain and LA stiffness (both P < 0.05), while there was no significant difference in baseline LA parameters between normal glucose tolerance (NGT) group and IGT/IFG group. The prevalence of LA reverse remodelling (≥15% decrease in the LA volume index at 6 months after CA) was significantly higher in NGT group compared with IGT/IFG and DM group (64.1 vs. 38.6 vs. 41.5%, P = 0.006). Both DM and IFG/IGT carry a significant risk of lack of LA reverse remodelling independent of baseline LA size and AF recurrence. CONCLUSION: Approximately 65% of patients with AF who underwent their first CA had abnormal glucose metabolism. Patients with DM had significantly impaired LA function compared with non-DM patients. Impaired glucose tolerance/IFG as well as DM carries significant risk of unfavourable LA reverse remodelling. Our observations may provide valuable information regarding the mechanisms and therapeutic strategies of glucose metabolism-related AF. Oxford University Press 2023-05-08 /pmc/articles/PMC10228626/ /pubmed/37155360 http://dx.doi.org/10.1093/europace/euad119 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Research Nakanishi, Koki Daimon, Masao Fujiu, Katsuhito Iwama, Kentaro Yoshida, Yuriko Hirose, Kazutoshi Mukai, Yasuhiro Yamamoto, Yuko Nakao, Tomoko Oshima, Tsukasa Matsubara, Takumi Shimizu, Yu Oguri, Gaku Kojima, Toshiya Hasumi, Eriko Morita, Hiroyuki Komuro, Issei Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation |
title | Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation |
title_full | Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation |
title_fullStr | Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation |
title_full_unstemmed | Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation |
title_short | Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation |
title_sort | prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228626/ https://www.ncbi.nlm.nih.gov/pubmed/37155360 http://dx.doi.org/10.1093/europace/euad119 |
work_keys_str_mv | AT nakanishikoki prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT daimonmasao prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT fujiukatsuhito prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT iwamakentaro prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT yoshidayuriko prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT hirosekazutoshi prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT mukaiyasuhiro prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT yamamotoyuko prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT nakaotomoko prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT oshimatsukasa prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT matsubaratakumi prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT shimizuyu prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT ogurigaku prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT kojimatoshiya prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT hasumieriko prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT moritahiroyuki prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation AT komuroissei prevalenceofglucosemetabolismdisordersanditsassociationwithleftatrialremodellingbeforeandaftercatheterablationinpatientswithatrialfibrillation |